These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3340199)

  • 21. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.
    Thisyakorn U; Pancharoen C; Ruxrungtham K; Ubolyam S; Khawplod P; Tantawichien T; Phanuphak P; Wilde H
    Clin Infect Dis; 2000 Jan; 30(1):218. PubMed ID: 10619765
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plaque-purified rabies virus (strains V-319) derived from a vampire bat (Desmodus rotundus) in Mexico: vaccine potential.
    Bijlenga G; Hernandez-Baumgarten EM
    Cornell Vet; 1984 Apr; 74(2):155-65. PubMed ID: 6467947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intradermal administration of HDC vaccine in the immunization of people against rabies].
    Svjetlicić M; Ljubicić M; Baklaić Z; Smerdel S; Vodopija I
    Lijec Vjesn; 1984 Sep; 106(9):379-80. PubMed ID: 6503605
    [No Abstract]   [Full Text] [Related]  

  • 26. Stability of recombinant vaccinia-rabies vaccine in veterinary use.
    Pastoret PP; Brochier B; Languet B; Duret C; Chappuis G; Desmettre P
    Dev Biol Stand; 1996; 87():245-9. PubMed ID: 8854024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabies treatment with vaccine of the Fuenzalida-Palacios type.
    Fábrega FP; Sepúlveda CA
    Bull Pan Am Health Organ; 1982; 16(1):40-6. PubMed ID: 7074254
    [No Abstract]   [Full Text] [Related]  

  • 28. Rabies vaccine (Babeş strain of fixed rabies virus) inactivated with betapropiolactone.
    Toacsen E; Serban O; Moraru S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):333-9. PubMed ID: 7340722
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serological evaluation of the efficacy of an antirabies vaccine in field dogs in Tunisia].
    Haddad N
    Ann Rech Vet; 1987; 18(1):63-7. PubMed ID: 3579184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
    Lalosević V; Lazarević-Ivanc L; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serologic studies of rabies vaccination in dogs in Switzerland].
    Bruckner L; Ackermann M; Müller HK; Kihm U
    Schweiz Arch Tierheilkd; 1986 Apr; 128(4):195-200. PubMed ID: 3715447
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immune rabies status of 200 vaccinated dogs from the canton of Zurich].
    Engels M; Flückiger M; Knüsli K; Wyler R
    Schweiz Arch Tierheilkd; 1982 Mar; 124(3):149-56. PubMed ID: 7201161
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine.
    Agarwal A; Mathur SB
    Hum Vaccin Immunother; 2022 Nov; 18(5):2085472. PubMed ID: 35714278
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine for man.
    Bijok U; Barth R; Gruschkau H; Vodopija I; Smerdel S; Kukla H; Geursen R
    J Commun Dis; 1984 Mar; 16(1):61-9. PubMed ID: 12055789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific activity of concentrated and purified cell culture rabies vaccine (CPCRV) from the strain Vnukovo -32-107 in an experiment with therapeutical immunization of humans.
    Selimov M; El'bert L; Aksenova T; Klyueva E; Gribencha L; Movsesyants A; Antonova L; Kamenetskaya I; Mishchenko N; Krupenin L; Bugayeva M; Yaretskaya V; Pyaeva A
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):83-94. PubMed ID: 7086124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Specific and nonspecific humoral response to vaccination with the anti-rabies vaccination agents Rabivac and Vnukovo-32].
    Wiedermannová D; Wiedermann D; Svrcek S; Novotná D; Macků M; Závadová J; Benísek Z
    Cas Lek Cesk; 1983 Aug; 122(32-33):980-3. PubMed ID: 6627311
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal antibodies against rabies in Thai puppies. A preliminary study.
    Kasempimolporn S; Mitmoonpitak C; Chaiyabutr N; Supakorn K; Brahmasa R; Sitprija V
    J Med Assoc Thai; 1996 Jan; 79(1):36-9. PubMed ID: 8867400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine.
    Horman JT; Rullán JV; Myers RA; Bond JO; Israel E; Joseph JM
    J Am Vet Med Assoc; 1987 Jul; 191(2):185-7. PubMed ID: 3610792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes recommended in use of human diploid cell rabies vaccine.
    Marwick C
    JAMA; 1985 Jul; 254(1):13-4. PubMed ID: 3999343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.